BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17395711)

  • 1. Reproducibility in protein profiling by MALDI-TOF mass spectrometry.
    Albrethsen J
    Clin Chem; 2007 May; 53(5):852-8. PubMed ID: 17395711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the information content of the MALDI analysis of biological fluids via multi-million shot analysis.
    Tsypin M; Asmellash S; Meyer K; Touchet B; Roder H
    PLoS One; 2019; 14(12):e0226012. PubMed ID: 31815946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALDI profiling of human lung cancer subtypes.
    Gámez-Pozo A; Sánchez-Navarro I; Nistal M; Calvo E; Madero R; Díaz E; Camafeita E; de Castro J; López JA; González-Barón M; Espinosa E; Fresno Vara JA
    PLoS One; 2009 Nov; 4(11):e7731. PubMed ID: 19890392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pkDACLASS: Open source software for analyzing MALDI-TOF data.
    Ndukum J; Atlas M; Datta S
    Bioinformation; 2011 Mar; 6(1):45-7. PubMed ID: 21464846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first decade of MALDI protein profiling: a lesson in translational biomarker research.
    Albrethsen J
    J Proteomics; 2011 May; 74(6):765-73. PubMed ID: 21376146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-TOF mass spectrometry and high-consequence bacteria: safety and stability of biothreat bacterial sample testing in clinical diagnostic laboratories.
    Tracz DM; Tober AD; Antonation KS; Corbett CR
    J Med Microbiol; 2018 Mar; 67(3):341-346. PubMed ID: 29458687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Reproducibility of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Bacterial and Yeast Identification.
    Westblade LF; Garner OB; MacDonald K; Bradford C; Pincus DH; Mochon AB; Jennemann R; Manji R; Bythrow M; Lewinski MA; Burnham CA; Ginocchio CC
    J Clin Microbiol; 2015 Jul; 53(7):2349-52. PubMed ID: 25926486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein identification by MALDI-TOF mass spectrometry.
    Webster J; Oxley D
    Methods Mol Biol; 2012; 800():227-40. PubMed ID: 21964792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins, Technological Advancement, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2024; 2758():3-47. PubMed ID: 38549006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A statistical approach to system suitability testing for mass spectrometry imaging.
    Sohn AL; Kibbe RR; Dioli OE; Hector EC; Bai H; Garrard KP; Muddiman DC
    Rapid Commun Mass Spectrom; 2024 May; 38(9):e9725. PubMed ID: 38456255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Reproducibility Challenge: A Review of Non-Nucleotide Biomarker Discovery Protocols from Body Fluids in Breast Cancer Diagnosis.
    Safari F; Kehelpannala C; Safarchi A; Batarseh AM; Vafaee F
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI-TOF MS Is an Effective Technique To Classify Specific Microbiota.
    Chen L; Gao W; Tan X; Han Y; Jiao F; Feng B; Xie J; Li B; Zhao H; Tu H; Yu S; Wang L
    Microbiol Spectr; 2023 Jun; 11(3):e0030723. PubMed ID: 37140390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser Ablation Synthesis in Solution and Nebulization of Silver-109 Nanoparticles for Mass Spectrometry and Mass Spectrometry Imaging.
    Płaza A; Kołodziej A; Nizioł J; Ruman T
    ACS Meas Sci Au; 2022 Feb; 2(1):14-22. PubMed ID: 36785587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of mass spectrometry imaging in traditional Chinese medicine: a review.
    Huang L; Nie L; Dai Z; Dong J; Jia X; Yang X; Yao L; Ma SC
    Chin Med; 2022 Mar; 17(1):35. PubMed ID: 35248086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
    Song Y; Xu X; Wang N; Zhang T; Hu C
    J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MALDI-TOF mass spectrometry-based haemoglobin chain quantification method for rapid screen of thalassaemia.
    Zhang J; Liu Z; Chen R; Ma Q; Lyu Q; Fu S; He Y; Xiao Z; Luo Z; Luo J; Wang X; Liu X; An P; Sun W
    Ann Med; 2022 Dec; 54(1):293-301. PubMed ID: 35098837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix enrichment by black phosphorus improves ionization and reproducibility of mass spectrometry of intact cells, peptides, and amino acids.
    Mandal G; Moráň L; Pečinka L; Vaňhara P; Havel J
    Sci Rep; 2022 Jan; 12(1):1175. PubMed ID: 35064192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward improvement of screening through mass spectrometry-based proteomics: ovarian cancer as a case study.
    Luu GT; Sanchez LM
    Int J Mass Spectrom; 2021 Nov; 469():. PubMed ID: 34744497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroblotting through Enzymatic Membranes to Enhance Molecular Tissue Imaging.
    Andrews WT; Bickner AN; Tobias F; Ryan KA; Bruening ML; Hummon AB
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1689-1699. PubMed ID: 34110793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell Disease.
    El Osta M; Naubourg P; Grunewald O; Renom G; Ducoroy P; Périni JM
    Int J Neonatal Screen; 2019 Sep; 5(3):31. PubMed ID: 33072990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.